Skip to main content
OpenTrials

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

749 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Brain Deficits in HIV/HCV Coinfected People Before and After Anti-HCV Therapy

NCT00747539

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Coinfection, +21 more
Locations
  • Kaiser Permanente Infectious Diseases, Antelope Valley Lancaster, California, United States
  • University of California, Los Angeles, School of Medicine Los Angeles, California, United States
  • AIDS Healthcare Foundation Los Angeles, California, United States
  • Veterans Administration Greater Los Angeles Healthcare System Los Angeles, California, United States
View Trial Details
Completed

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy

NCT01485991

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Bakersfield, California, United States
  • San Diego, California, United States
  • Aurora, Colorado, United States
  • Washington D.C., District of Columbia, United States
View all 137 locations
View Trial Details
Completed

Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients

NCT01970904

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Cologne, Germany
  • Novartis Investigative Site Düsseldorf, Germany
View all 25 locations
View Trial Details
Completed

A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study

NCT01323244

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Bakersfield, California, United States
  • Los Angeles, California, United States
  • San Diego, California, United States
  • Englewood, Colorado, United States
View all 72 locations
View Trial Details
Completed

Dutch Acute HCV in HIV Study (DAHHS)

NCT01912495

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
Locations
  • Erasmus MC Rotterdam, South Holland, Netherlands
  • AMC Amsterdam, Netherlands
  • OLVG Amsterdam, Netherlands
  • Slotervaart Amsterdam, Netherlands
View Trial Details

Related conditions